Sagimet Biosciences (SGMT) News Today $9.14 +1.81 (+24.69%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$9.15 +0.01 (+0.11%) As of 10/24/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SGMT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Sagimet Biosciences Stock Soars After Positive Data For Experimental Drug In Acne StudyOctober 24 at 4:07 PM | msn.comDenifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology ...October 24 at 11:06 AM | finance.yahoo.comSagimet Biosciences' Denifanstat Meets All Endpoints in Phase 3 Acne Clinical Trial, NDA Submission Planned in ChinaOctober 24 at 7:31 AM | quiverquant.comQDenifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology ConferenceOctober 24 at 7:00 AM | globenewswire.comClear Street Initiates Coverage of Sagimet Biosciences (SGMT) with Buy RecommendationOctober 22 at 8:33 PM | msn.comSagimet Biosciences Inc. $SGMT Shares Sold by FNY Investment Advisers LLCOctober 22 at 7:15 AM | marketbeat.comSagimet Biosciences initiated with a Buy at Clear StreetOctober 21, 2025 | msn.comSagimet Biosciences (NASDAQ:SGMT) Upgraded to Hold at Wall Street ZenOctober 19, 2025 | marketbeat.comSagimet Biosciences (NASDAQ:SGMT) Stock Rating Upgraded by Zacks ResearchOctober 16, 2025 | marketbeat.comSagimet Biosciences Inc. Announces Participation in Upcoming Investor ConferencesOctober 14, 2025 | quiverquant.comQSagimet Biosciences Announces Participation in Three Upcoming Investor ConferencesOctober 14, 2025 | globenewswire.comAscletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products AdministrationOctober 14, 2025 | prnewswire.comSagimet Biosciences (NASDAQ:SGMT) Rating Lowered to Sell at Wall Street ZenOctober 11, 2025 | marketbeat.comSagimet Biosciences' (SGMT) Sell (D-) Rating Reiterated at Weiss RatingsOctober 9, 2025 | marketbeat.comSagimet Biosciences Inc. (NASDAQ:SGMT) Receives Average Rating of "Moderate Buy" from AnalystsOctober 9, 2025 | marketbeat.comSagimet Biosciences to present Phase 2b FASCINATE-2 study resultsOctober 7, 2025 | msn.comDenifanstat Advances: Sagimet Builds Momentum Toward 2026 ReadoutsOctober 7, 2025 | seekingalpha.comSagimet Biosciences to Present Positive Results for Denifanstat in Advanced Fibrosis at AASLD 2025October 7, 2025 | quiverquant.comQSagimet Biosciences Announces Upcoming Presentation at AASLD—The Liver Meeting® 2025October 7, 2025 | globenewswire.comCanaccord Genuity Maintains Sagimet Biosciences (SGMT) Buy RecommendationOctober 2, 2025 | msn.comCanaccord Genuity Group Reiterates Buy Rating for Sagimet Biosciences (NASDAQ:SGMT)October 2, 2025 | marketbeat.comSagimet announces dosing in Phase 1 PK trial of denifanstat with resmetiromOctober 1, 2025 | msn.comSagimet Biosciences Announces Dosing of First Participants in Phase 1 PK Clinical Trial for Denifanstat and Resmetirom CombinationOctober 1, 2025 | finance.yahoo.comGoldman Sachs Group Inc. Sells 109,464 Shares of Sagimet Biosciences Inc. $SGMTOctober 1, 2025 | marketbeat.comSagimet Biosciences Announces Upcoming Panel Participation at Fierce Biotech WeekSeptember 24, 2025 | markets.businessinsider.comSagimet Biosciences (NASDAQ:SGMT) Upgraded at Wall Street ZenSeptember 21, 2025 | marketbeat.comSagimet Biosciences reports data from Phase 3 trial on denifanstatSeptember 17, 2025 | msn.comPositive Phase 3 Results for Denifanstat for the Treatment of Moderate to Severe Acne to be Presented at the EADV Congress 2025 by Partner AscletisSeptember 17, 2025 | globenewswire.comSagimet Biosciences Inc. (NASDAQ:SGMT) Given Consensus Recommendation of "Buy" by BrokeragesSeptember 16, 2025 | marketbeat.comWall Street Zen Downgrades Sagimet Biosciences (NASDAQ:SGMT) to SellSeptember 15, 2025 | marketbeat.comSagimet Biosciences announces presentations at MASH Drug Development SummitSeptember 10, 2025 | msn.comSagimet Biosciences Announces Upcoming Presentations at 9th Annual MASH Drug Development SummitSeptember 10, 2025 | globenewswire.comAlyeska Investment Group L.P. Sells 98,069 Shares of Sagimet Biosciences Inc. $SGMTSeptember 8, 2025 | marketbeat.comWall Street Zen Upgrades Sagimet Biosciences (NASDAQ:SGMT) to "Hold"September 8, 2025 | marketbeat.comSagimet Biosciences Inc. (SGMT) Presents At Cantor Global Healthcare Conference 2025 TranscriptSeptember 7, 2025 | seekingalpha.comSagimet Biosciences: Strong Denifanstat Pipeline Progress, Funding Overhang Keeps Stock At HoldAugust 31, 2025 | seekingalpha.comSagimet Gains Momentum As FDA Eases Path For MASH Drug DevelopmentAugust 29, 2025 | seekingalpha.comSagimet Biosciences to Participate in Two Upcoming Investor ConferencesAugust 26, 2025 | globenewswire.comSagimet Biosciences Inc. (NASDAQ:SGMT) Given Average Recommendation of "Buy" by BrokeragesAugust 21, 2025 | marketbeat.comWhat is Wedbush's Estimate for SGMT Q2 Earnings?August 16, 2025 | marketbeat.comSagimet Biosciences Enters New Sales Agreement with LeerinkAugust 15, 2025 | msn.comSagimet Biosciences Inc.: Sagimet Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate UpdatesAugust 13, 2025 | finanznachrichten.deSagimet Biosciences Reports Positive Phase 3 Results for Denifanstat in Acne and Initiates Phase 1 Trials for FASN InhibitorsAugust 13, 2025 | quiverquant.comQSagimet Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate UpdatesAugust 13, 2025 | globenewswire.comWedbush Initiates Coverage of Sagimet Biosciences (SGMT) with Outperform RecommendationAugust 12, 2025 | msn.comWedbush Begins Coverage on Sagimet Biosciences (NASDAQ:SGMT)August 12, 2025 | marketbeat.comSagimet Biosciences initiated with an Outperform at WedbushAugust 11, 2025 | msn.comWhat is HC Wainwright's Estimate for SGMT Q2 Earnings?August 11, 2025 | marketbeat.comSagimet Biosciences' (SGMT) "Buy" Rating Reaffirmed at HC WainwrightAugust 8, 2025 | marketbeat.comSagimet Biosciences (SGMT) Projected to Post Earnings on WednesdayAugust 6, 2025 | marketbeat.com Get Sagimet Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGMT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SGMT Media Mentions By Week SGMT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGMT News Sentiment▼0.740.93▲Average Medical News Sentiment SGMT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGMT Articles This Week▼93▲SGMT Articles Average Week Get the Latest News and Ratings for SGMT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Sagimet Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Cronos Group News Today Oculis News Today Phathom Pharmaceuticals News Today Rapport Therapeutics News Today BGM Group News Today ProKidney News Today Valneva News Today Kura Oncology News Today Arbutus Biopharma News Today Maravai LifeSciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGMT) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sagimet Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SGMT Stock Alerts